معرفی
Professor Peter Openshaw is a renowned respiratory physician and mucosal immunologist at Imperial College London, holding the title of Professor of Experimental Medicine since 1996. He currently serves as Proconsul at the university and has been a pivotal figure in immunology, including leadership roles in the British Society for Immunology (2013–2018) and advisory committees like SAGE and NERVTAG. His research focuses on viral immunity, particularly RSV and influenza, with groundbreaking contributions to understanding host-pathogen interactions and vaccine development. Openshaw led major consortia such as MOSAIC (influenza) and ISARIC4C (COVID-19), and pioneered human experimental infection models to accelerate vaccine research through the HIC-Vac consortium.
**Education**: BSc and MB BS from University of London; PhD in Immunology from National Institute for Medical Research/Brunel University (1988). Recognized as a Fellow of the Royal College of Physicians (1994).
**Research Focus**: Pathogenesis of viral lung disease, immune modulation, aging and immunity, and translational vaccine strategies. Key contributions include defining T cell roles in RSV pathogenesis, mucosal sampling techniques, and the concept of 'innate preparedness' in respiratory infections.
**Awards & Recognition**: Chanock Memorial Award (2012), EFIS Metchnikoff-Ehrlich Medal (2014), CBE (2022), and the 2024 Per Brandtzaeg Award. He is an Emeritus NIHR Senior Investigator.
**Grants & Networks**: Theme Lead for Respiratory Disease at Imperial Biomedical Research Centre, member of UK Vaccine Network, and founder of the ISARIC4C and HIC-Vac initiatives. His work bridges clinical research and public health policy, particularly during pandemic responses.
**Labs & Collaborations**: Active in the National Heart & Lung Institute, collaborating with global networks like the Microbiome and Immuno-Pathology Networks. His research integrates clinical studies with molecular and systems immunology approaches.
